These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 35984673)
61. Formation of Prenylated Chalcone Xanthohumol Cocrystals: Single Crystal X-Ray Diffraction, Vibrational Spectroscopic Study Coupled with Multivariate Analysis. Budziak I; Arczewska M; Kamiński DM Molecules; 2019 Nov; 24(23):. PubMed ID: 31766540 [TBL] [Abstract][Full Text] [Related]
62. Supramolecular hydrogen-bonding patterns in 1:1 cocrystals of 5-fluorouracil with 4-methylbenzoic acid and 3-nitrobenzoic acid. Mohana M; Muthiah PT; McMillen CD Acta Crystallogr C Struct Chem; 2017 Mar; 73(Pt 3):259-263. PubMed ID: 28257022 [TBL] [Abstract][Full Text] [Related]
63. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. Remenar JF; Morissette SL; Peterson ML; Moulton B; MacPhee JM; Guzmán HR; Almarsson O J Am Chem Soc; 2003 Jul; 125(28):8456-7. PubMed ID: 12848550 [TBL] [Abstract][Full Text] [Related]
64. Naringenin Cocrystals Prepared by Solution Crystallization Method for Improving Bioavailability and Anti-hyperlipidemia Effects. Cui W; He Z; Zhang Y; Fan Q; Feng N AAPS PharmSciTech; 2019 Feb; 20(3):115. PubMed ID: 30771018 [TBL] [Abstract][Full Text] [Related]
65. Extending the supramolecular synthon based fragment approach (SBFA) for transferability of multipole charge density parameters to monofluorobenzoic acids and their cocrystals with isonicotinamide: importance of C-H···O, C-H···F, and F···F intermolecular regions. Hathwar VR; Thakur TS; Dubey R; Pavan MS; Row TN; Desiraju GR J Phys Chem A; 2011 Nov; 115(45):12852-63. PubMed ID: 21809890 [TBL] [Abstract][Full Text] [Related]
66. Cocrystals of Praziquantel with Phenolic Acids: Discovery, Characterization, and Evaluation. Yang S; Liu Q; Ji W; An Q; Song J; Xing C; Yang D; Zhang L; Lu Y; Du G Molecules; 2022 Mar; 27(6):. PubMed ID: 35335384 [TBL] [Abstract][Full Text] [Related]
67. Dosage form designs for the controlled drug release of solid dispersions. Tran PHL; Tran TTD Int J Pharm; 2020 May; 581():119274. PubMed ID: 32234566 [TBL] [Abstract][Full Text] [Related]
68. Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt. Sanphui P; Tothadi S; Ganguly S; Desiraju GR Mol Pharm; 2013 Dec; 10(12):4687-97. PubMed ID: 24168322 [TBL] [Abstract][Full Text] [Related]
69. Cocrystal of Apixaban-Quercetin: Improving Solubility and Bioavailability of Drug Combination of Two Poorly Soluble Drugs. Zhang L; Kong D; Wang H; Jiao L; Zhao X; Song J; Yang D; Yang H; Yang S; Du G; Lu Y Molecules; 2021 May; 26(9):. PubMed ID: 34063645 [TBL] [Abstract][Full Text] [Related]
70. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435 [TBL] [Abstract][Full Text] [Related]
71. Cocrystals of Hydrochlorothiazide: Solubility and Diffusion/Permeability Enhancements through Drug-Coformer Interactions. Sanphui P; Devi VK; Clara D; Malviya N; Ganguly S; Desiraju GR Mol Pharm; 2015 May; 12(5):1615-22. PubMed ID: 25800383 [TBL] [Abstract][Full Text] [Related]
72. Solid phase drug-drug pharmaceutical co-crystal formed between pyrazinamide and diflunisal: Structural characterization based on terahertz/Raman spectroscopy combining with DFT calculation. Wu X; Wang Y; Xue J; Liu J; Qin J; Hong Z; Du Y Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jun; 234():118265. PubMed ID: 32203686 [TBL] [Abstract][Full Text] [Related]
76. Crystal structures, dissolution and pharmacokinetic study on a novel phosphodiesterase-4 inhibitor chlorbipram cocrystals. Zhou J; Li L; Zhang H; Xu J; Huang D; Gong N; Han W; Yang X; Zhou Z Int J Pharm; 2020 Feb; 576():118984. PubMed ID: 31870960 [TBL] [Abstract][Full Text] [Related]
77. [Polymorph transformation of solid drugs]. Zhang Q; Mei XF Yao Xue Xue Bao; 2015 May; 50(5):521-7. PubMed ID: 26234130 [TBL] [Abstract][Full Text] [Related]
78. Multicomponent ternary cocrystals of the sulfonamide group with pyridine-amides and lactams. Bolla G; Nangia A Chem Commun (Camb); 2015 Nov; 51(85):15578-81. PubMed ID: 26355724 [TBL] [Abstract][Full Text] [Related]
79. Solid-state and particle size control of pharmaceutical cocrystals using atomization-based techniques. O'Sullivan A; Long B; Verma V; Ryan KM; Padrela L Int J Pharm; 2022 Jun; 621():121798. PubMed ID: 35525471 [TBL] [Abstract][Full Text] [Related]
80. Oral bioavailability enhancement of β-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion. Liu C; Liu Z; Chen Y; Chen Z; Chen H; Pui Y; Qian F Eur J Pharm Biopharm; 2018 Mar; 124():73-81. PubMed ID: 29305142 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]